Response to ‘Procalcitonin is a biomarker for disease severity rather than bacterial coinfection in COVID-19’ by Heer et alHeer et al의 'Procalcitonin은 COVID-19에서 박테리아 동시 감염보다 질병 중증도에 대한 바이오마커'에 대한 반응 Published on 2022-08-012022-09-11 Journal: European journal of emergency medicine : official [키워드] Bacterial Biomarker COVID-19 disease severity response [저자] Stefano Malinverni, Maïa Nuñez, Fatima Bouazza [Category] MERS, 바이오마커, PMC URL [DOI] 10.1097/MEJ.0000000000000943 [Article Type] Article [Source] PMC All Keywords 【제목키워드】 COVID-19, Biomarker, disease severity, response, Bacterial,